Please use this identifier to cite or link to this item:
http://earsiv.odu.edu.tr:8080/xmlui/handle/11489/2602| Title: | Evaluation of Aqueous Flare Levels Following Intravitreal Ranibizumab Injection for Neovascular Age-related Macular Degeneration |
| Authors: | Batyodlu, Figen Demirel, Sibel Ozmert, Emin Uzun, Aslihan Yalcindag, Fatime Nilufer Ordu Üniversitesi 0000-0002-5787-3879 0000-0002-6430-6565 |
| Keywords: | Age-related macular degeneration; anterior chamber; aqueous flare; intravitreal injection; ranibizumab INTRAOCULAR INFLAMMATION; BEVACIZUMAB; OUTCOMES; ANCHOR |
| Issue Date: | 2017 |
| Publisher: | TAYLOR & FRANCIS INC, 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA |
| Abstract: | Purpose: To evaluate aqueous flare levels following intravitreal ranibizumab injection for neovascular age-related macular degeneration (AMD). Methods: In total, 81 eyes of 79 patients who underwent intravitreal ranibizumab injection for neovascular AMD were included. Aqueous flare was evaluated before pupillary dilatation with Kowa FM-600 laser flare meter at baseline, and 1 day, and 1 month after intravitreal administration of ranibizumab 0.5 mg (0.05 mL). Results: The mean anterior chamber flare was 10.7 +/- 6.8 (range: 1.5-35.4) ph/ms before the injection, 12.5 +/- 8.9 (range: 0.3-43) ph/ms on the first day, and 9.9 +/- 5.7 (range: 0.2-28.4) ph/ms in the first month. On the first day, a subtle increasing of flare was observed. However, the difference between the mean aqueous flare levels at baseline and postoperative first day and first month was not statistically different (p>0.05). Conclusions: No significant short-term intraocular inflammation was noted in these eyes receiving ranibizumab for the treatment of neovascular AMD. |
| URI: | http://doi.org/10.3109/09273948.2015.1108445 https://www.tandfonline.com/doi/full/10.3109/09273948.2015.1108445 http://earsiv.odu.edu.tr:8080/xmlui/handle/11489/2602 |
| Appears in Collections: | Cerrahi Tıp Bilimleri |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.